"Low-Cost Device Enhances Safety of Cell Therapy"

Scientists at MIT and the Singapore-MIT Alliance for Research and Technology have developed a low-cost microfluidic cell sorter that can remove potentially tumor-forming undifferentiated cells from induced pluripotent stem cell batches, without causing damage to fully-formed progenitor cells. This device, which can sort more than 3 million cells per minute and be mass-produced at low cost, aims to improve the safety and effectiveness of cell therapy treatments for spinal cord injuries.